Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Anand Shah, Erik Bloomquist, Shenghui Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2018
U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
Harpreet Singh, Amanda J Walker, Laleh Amiri-Kordestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C Krauss, Xin Gao, Liang Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 13, 2016
Clinician Perspectives on Current Issues in Lung Cancer Drug Development
Saiama N Waqar, Philip D Bonomi, Ramaswamy Govindan, et al.
JAMA Oncology
|
November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer
Sundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2020
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1
Preeti Narayan, Sakar Wahby, Jennifer J Gao, et al.
JAMA Oncology
|
November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
Andrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2014
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer
Laleh Amiri-Kordestani, Gideon M Blumenthal, Qiang Casey Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2015
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S Herbst, David R Gandara, Fred R Hirsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2018
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
Gwynn Ison, Lynn J Howie, Laleh Amiri-Kordestani, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Anand Shah, Erik Bloomquist, Shenghui Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2018
U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
Harpreet Singh, Amanda J Walker, Laleh Amiri-Kordestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C Krauss, Xin Gao, Liang Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 13, 2016
Clinician Perspectives on Current Issues in Lung Cancer Drug Development
Saiama N Waqar, Philip D Bonomi, Ramaswamy Govindan, et al.
JAMA Oncology
|
November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer
Sundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2020
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1
Preeti Narayan, Sakar Wahby, Jennifer J Gao, et al.
JAMA Oncology
|
November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
Andrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2014
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer
Laleh Amiri-Kordestani, Gideon M Blumenthal, Qiang Casey Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2015
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S Herbst, David R Gandara, Fred R Hirsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2018
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
Gwynn Ison, Lynn J Howie, Laleh Amiri-Kordestani, et al.
Page
of 9